Literature DB >> 7495059

Haemostasis factors in angina pectoris; relation to gender, age and acute-phase reaction. Results of the ECAT Angina Pectoris Study Group.

F Haverkate1, S G Thompson, F Duckert.   

Abstract

The ECAT Angina Pectoris Study is a European multicentre study with the aim of investigating the pathogenetic and predictive role of haemostatic factors in the progression of coronary heart disease. It is the largest study performed up to now with regard to both the number of patients with angina pectoris (n = 3043) and the number of haemostasis assays (n = 23) included. The present paper presents baseline cross-sectional data with particular reference to the relationship of haemostatic factors with each other and with the coronary risk factors age, gender and acute-phase reaction (1). Two clusters of haemostatic factors could be distinguished in which each variable was correlated (P < 0.001) to every other variable: (a) Eight fibrinolysis assays including t-PA, PAI-1 and euglobulin clot lysis time (ECLT), for which PAI-1 appeared to be the dominating factor; (b) antithrombin III, protein C, alpha 2-antiplasmin and plasminogen, the interdependence of which has no obvious explanation. (2). Twelve out of the 23 haemostasis assays were associated (P < or = 0.01) with age. Except for alpha 2-antiplasmin, these relationships indicated an increased tendency to thrombosis with increasing age. (3). Gender differences found in 14 haemostasis parameters do not indicate a consistent difference in the tendency to thrombosis between men and women. Eight haemostasis parameters were on average higher in female than in male patients in the age group over 50 years. (4). C-reactive protein, an acute-phase reactant, was positively correlated (P < 0.001) with fibrinogen, factor VIIIc, von Willebrand factor, the fibrinolysis assays t-PA, PAI-1, ECLT and plasminogen.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7495059

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Association between plasma plasminogen activator inhibitor-1 and survival in colorectal cancer. Measuring C reactive protein concentrations may be more useful.

Authors:  N Sattar; D C McMillan
Journal:  BMJ       Date:  1998-09-12

2.  Inflammatory responses and coronary heart disease.

Authors:  M A Mendall
Journal:  BMJ       Date:  1998-03-28

Review 3.  Fibrinolytic function and coronary risk.

Authors:  I Juhan-Vague; P Morange; M Christine Alessi
Journal:  Curr Cardiol Rep       Date:  1999-07       Impact factor: 2.931

4.  In young post-myocardial infarction male patients elevated plasminogen activator inhibitor-1 correlates with insulin resistance and endothelial dysfunction.

Authors:  Barbara Eržen; Mišo Šabovič
Journal:  Heart Vessels       Date:  2012-09-22       Impact factor: 2.037

Review 5.  Inflammatory and thrombotic mechanisms in coronary atherosclerosis.

Authors:  D Tousoulis; G Davies; C Stefanadis; P Toutouzas; J A Ambrose
Journal:  Heart       Date:  2003-09       Impact factor: 5.994

6.  Linkage study of fibrinogen levels: the Strong Heart Family Study.

Authors:  Lyle G Best; Kari E North; Xia Li; Vittorio Palmieri; Jason G Umans; Jean MacCluer; Sandy Laston; Karin Haack; Harald Goring; Vincent P Diego; Laura Almasy; Elisa T Lee; Russell P Tracy; Shelley Cole
Journal:  BMC Med Genet       Date:  2008-08-12       Impact factor: 2.103

Review 7.  COVID-19, Renin-Angiotensin System and Endothelial Dysfunction.

Authors:  Razie Amraei; Nader Rahimi
Journal:  Cells       Date:  2020-07-09       Impact factor: 6.600

8.  Circulating matrix metalloproteinase-9 is associated with cardiovascular risk factors in a middle-aged normal population.

Authors:  Peter Garvin; Lennart Nilsson; John Carstensen; Lena Jonasson; Margareta Kristenson
Journal:  PLoS One       Date:  2008-03-12       Impact factor: 3.240

9.  Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model.

Authors:  Yzabella Alves Campos Nogueira; Loredana Nilkenes Gomes da Costa; Carlos Emilio Levy; Fernanda Andrade Orsi; Franciele de Lima; Joyce M Annichinno-Bizzacchi; Erich Vinicius De Paula
Journal:  PLoS One       Date:  2019-12-31       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.